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Introduction: FDA-mandated product standards that drastically reduce nicotine content in 
cigarettes may result in decreased smoking and thus, improved health outcomes for millions of 
U.S. smokers. One issue is whether the rate of smoking at reduced nicotine contents would be 
different for current smokers from individuals who start smoking for the first time at the reduced 
content. Method: 48 rats were given the opportunity to self-administer at one of four low nicotine 
doses (15, 7.5, 3.75, 0.0 µg/kg/infusion) before and after self-administering a higher dose of 
nicotine (60 µg/kg/infusion). A second group of 57 rats acquired self-administration at the high 
nicotine dose before experiencing reduction. A cocktail of other cigarette constituents was 
included in the vehicle and remained constant across the study. Results: The rate of self-
administration across the low doses (including vehicle) was higher following self-administration 
of a high dose. Rates of self-administration following reduction from the high nicotine dose were 
the same regardless of whether the rats originally acquired at a low dose or the high dose. The 
effect of self-administering a high nicotine dose was highest for a threshold dose (7.5 
µg/kg/infusion). Discussion: The present study suggests rate of self-administering low nicotine 
doses may be increased by having a history of high dose self-administration. The large effect at a 
threshold nicotine dose may indicate a shift in the threshold for maintaining behavior as a result 
of experience with higher doses of nicotine. These data would support the idea that current 
smokers may smoke at a higher intensity following nicotine reduction than individuals who 
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begin smoking for the first time at the reduced rate. Furthermore, the rate of self-administration 
following reduction was the same regardless of whether rats acquired at the high dose of nicotine 
or experienced a low dose before being changed over to a high nicotine dose. 
 
 vi 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS .......................................................................................................... IX 
1.0 INTRODUCTION ........................................................................................................ 1 
2.0 METHOD ..................................................................................................................... 5 
2.1 SUBJECTS ........................................................................................................... 5 
2.2 APPARATUS ....................................................................................................... 5 
2.3 DRUGS ................................................................................................................. 6 
2.4 PROCEDURES .................................................................................................... 7 
2.4.1 Surgery ............................................................................................................. 7 
2.4.2 Habituation....................................................................................................... 7 
2.4.3 Self-Administration ......................................................................................... 8 
2.4.3.1 Phase 1 .................................................................................................... 8 
2.4.3.2 Phase 2 .................................................................................................... 9 
2.4.3.3 Phase 3 .................................................................................................... 9 
2.5 DATA ANALYSIS ............................................................................................. 10 
3.0 RESULTS ................................................................................................................... 12 
4.0 DISCUSSION ............................................................................................................. 18 
BIBLIOGRAPHY ....................................................................................................................... 23 
 vii 
 LIST OF TABLES 
 
Table 1. Nicotine doses experienced in each phase for each group ................................................ 8 
 viii 
LIST OF FIGURES 
 
Figure 1. Earned infusions across acquisition for all groups ........................................................ 13 
Figure 2. Earned infusions at each nicotine dose in Phase 1 (LHL groups), Phase 2, and Phase 3 
(LHL & HL groups) ...................................................................................................................... 15 
Figure 3. Earned infusions for individual rats in LHL groups in each phase of the experiment. . 17 
 ix 
ACKNOWLEDGMENTS 
 
Thank you my committee and other members of the lab whose input was invaluable in 
the design and interpretation of this study, including Eric C. Donny, Alan F. Sved, Kenneth A. 
Perkins, Deanne M. Buffalari, and Rachel L Schassburger. Thank you to the technical assistants 
and undergraduates who assisted in data collection including: Maysa Gharib, Josh Alberts, Emily 
Pitzer, Angela Lutheran, Melinda Moran, and Richard Jacobson. 
 
 
 1 
1.0  INTRODUCTION 
New policies and strategies are needed to reduce tobacco use. Cigarette smoking results 
in about 443,000 deaths each year, but despite the widely publicized health risks, 19.3% of 
Americans are still smokers (CDC, 2011). Two thirds of smokers express that they would like to 
quit smoking, but only 6.2% of smokers actually quit each year (CDC, 2011). The difficulty in 
quitting smoking is generally attributed to an addiction to nicotine (Stolerman & Jarvis, 1995). 
In 2009 Congress passed the Family Smoking Prevention and Tobacco Control Act, 
which permits the regulation of tobacco products and their constituents, including the reduction 
of nicotine to any non-zero level (US Congress, 2009). Benowitz and Henningfield (1994) 
suggested nicotine reduction as a strategy for reducing the prevalence of smoking almost 20 
years ago, but the idea has recently gained more attention with the new legislation. The outcome 
of a nicotine reduction policy is uncertain because some evidence suggests that smokers 
compensate for the decrease in nicotine level-- attempting to maintain a specific level of nicotine 
(Scherer, 1999). Indeed, evidence from human research and non-human self-administration 
paradigms shows that relatively small decreases in nicotine dose result in changes in behavior to 
maintain, at least partially, nicotine intake (Harris, Pentel, & LeSage, 2009; Scherer, 1999). 
However, there are some theories and experimental evidence to suggest that compensatory 
increases in behavior are likely to exist only over a range of doses and that at very low nicotine 
doses, smoking behavior will decrease (Benowitz et al., 2012; Benowitz et al., 2007; 
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DeGrandpre, Bickel, Hughes, & Higgins, 1992; Hatsukami et al., 2010; Kozlowski & Herman, 
1984).  
Clinical research will help identify the nicotine dose necessary to maintain dependence in 
current smokers. However, a history of smoking may shift the dose-response curve for the 
reinforcing effects of nicotine to the left (sensitization) or to the right (tolerance). In this case, a 
nicotine reduction policy may impact individuals who start smoking at the reduced content 
differently from those who were smoking prior to policy implementation. Those individuals 
without a history of smoking cigarettes at higher nicotine contents may have much higher or 
lower intensity of smoking at the reduced contents. Research regarding the impact of prior 
smoking experience is critical in determining how best to implement a reduction in nicotine 
content. 
Experimental research cannot ethically investigate the rate of smoking at low nicotine 
contents using subjects who have not yet started smoking. Thus, a policy implementing nicotine 
reduction will likely rely on non-human research for information about how a history of smoking 
might shift the rate of smoking across a range of nicotine doses. The self-administration 
paradigm, in which animals engage in a response that results in delivery of drugs, is likely to be 
the most informative. Modeling smoking status in a rat may never be possible, but 
methodological preparations can incorporate many of the most important elements. 
Environmental stimuli can be paired with nicotine infusions in the same way that smokers 
experience cues paired with their smoking. Additionally, some cigarette constituents other than 
nicotine may promote self-administration on their own or increase the rates of self-administration 
when combined with nicotine (Bardo, Green, Crooks, & Dwoskin, 1999; Belluzzi, Wang, & 
Leslie, 2005; Clemens, Caille, Stinus, & Cador, 2009; Guillem et al., 2005; Villegier, Lotfipour, 
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McQuown, Belluzzi, & Leslie, 2007). A cocktail of these other constituents can be included 
along with nicotine infusions to better mimic the experience of a smoker. Even with these 
methodological considerations, the specific doses in either of the two dose-response curves will 
not translate between non-human animals and humans.  However, the relation between the dose-
response curves of the two populations may tell us about the functional effects of a history of 
self-administering a higher dose of nicotine.  
Substantial research exists regarding the dose-response curve for acquisition of nicotine 
self-administration in naïve animals (Chen, Matta, & Sharp, 2007; Cox, Goldstein, & Nelson, 
1984; Donny et al., 1998; Sorge & Clarke, 2009). However, studies are not typically designed to 
compare acquisition and maintenance dose-response curves, and comparing across studies is 
difficult because of methodological differences across studies including strain of rat, nicotine-
paired environmental stimuli, schedule(s) of reinforcement, and access schedule. One small 
study provides evidence that may be useful in determining how a history of self-administration 
shifts the dose response curve for low-dose nicotine self-administration. Cox et al. (1984) found 
that following acquisition, a nicotine dose reduction produced an increase in behavior even 
though the dose used for reduction failed to produce acquisition in a separate group of rats. 
Hence, these results suggest that prior self-administration experience may reduce the threshold 
nicotine dose required to maintain dependence. However, research examining the effect of a 
history of experimenter-administered nicotine exposure on the reinforcing effectiveness of 
nicotine is mixed. Some studies have found that nicotine pre-exposure results in increased 
sensitivity to nicotine (Adriani et al., 2003; Shoaib, Stolerman, & Kumar, 1994; Tammimaki et 
al., 2008), while others have found the opposite (Adriani, Deroche-Gamonet, Le Moal, Laviola, 
& Piazza, 2006; Shoaib, Schindler, & Goldberg, 1997).  
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 The present experiment directly examined how self-administration behavior at 
low doses of nicotine is changed by a history of self-administering a relatively high dose of 
nicotine. Rats were given the opportunity to self-administer one of four low nicotine doses (15, 
7.5, 3.75, and 0 µg/kg/infusion) before and after self-administering a relatively high nicotine 
dose (60 µg/kg/infusion). A separate group of rats acquired self-administration at the higher 
nicotine dose (60 µg/kg/infusion) before reduction. 
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2.0  METHOD 
2.1 SUBJECTS 
Male Sprague-Dawley rats (Harlan-Farms, IN), weighing between 188 and 217 grams 
upon arrival (approximately post-natal day 49) were used as subjects (N=105). Rats were 
individually-housed in wire-mesh, hanging cages in a temperature-controlled room kept between 
68 and 70 degrees Fahrenheit. Rats were kept on a reverse light-dark 12:12 hour schedule (lights 
off: 7AM). Rats received free access to water in their home cages throughout the experiment, 
and were given unlimited access to Purina Rat Chow for the first week after arrival. Once 
surgeries began, rats were restricted to 20 g/day of chow for the remainder of the experiment.  In 
this past, this food schedule has been shown to result in weight gain of approximately 10 g/week 
(Donny, Caggiula, Knopf, & Brown, 1995).  
2.2 APPARATUS 
Thirty four commercial operant chambers (30.5cm X 24.1 cm X 21.0 cm; ENV-008CT; 
Med-Associates) were used in the present experiment. Each chamber was closed inside a sound-
attenuating cubicle with a ventilation fan. Chambers contained two nosepoke holes, each 2.5 cm 
in diameter, on the right side of the chamber located 5 cm from the chamber base to the base of 
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the hole. A white stimulus light, 3.5 cm in diameter, was located 6.25 cm above the top of each 
nosepoke. Each chamber also contained a houselight on the same wall. The houselight was 2 cm 
in diameter, illuminated red, and located 1 cm below the ceiling of the chamber. During sessions, 
rats were connected to a swivel system that delivers IV infusions while allowing for unrestricted 
movement within the chamber.  
2.3 DRUGS 
Nicotine hydrogen tartrate salt (Sigma, St. Louis, MO), and a cocktail of other cigarette 
constituents including: acetaldehyde (Sigma, St. Louis, MO), harman (Sigma, St. Louis, MO), 
norharman (Sigma, St. Louis, MO), anabasine (Sigma, St. Louis, MO), anatabine (Toronto 
Research Chemicals, Inc), myosmine (Sigma, St. Louis, MO), cotinine (Sigma, St. Louis, MO), 
and nornicotine (Sigma, St. Louis, MO) were dissolved in 0.9% saline.  The doses of nicotine 
used for self-administration were 60, 15, 7.5, and 3.75 µg/kg/infusion. At the beginning of the 
experiment, a dosing error was made and rats were also exposed to doses of nicotine one tenth of 
the intended dose for 8 sessions. The doses of nicotine were chosen to be a range that will 
capture the threshold for maintaining behavior after reduction. The doses of the other 
constituents were 16 μg/kg/infusion (acetaldehyde), 0.1 μg/kg/infusion (harman), 0.3 
μg/kg/infusion (norharman), 0.9 μg/kg/infusion (anabasine and nornicotine), 0.09 μg/kg/infusion 
(anatabine, myosmine and cotinine) (free-base concentration) .  The constituent doses were 
chosen based on past studies that found an effect of the constituents (Belluzzi et al., 2005; 
Clemens et al., 2009) or to be proportional to the amount found in cigarette smoke given 30 
µg/kg/inf nicotine (harman and norharman) (Herraiz, 2004). All drug solutions were adjusted to 
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7.0 (±0.2) pH with dilute NaOH.  All solutions, including the vehicle, were sterilized by being 
passed through a 0.22 m filter. During sessions, drugs were delivered in less than 1 s at a 
volume of 0.1 ml/kg/infusion. 
2.4 PROCEDURES 
2.4.1 Surgery 
During surgery, rats were anesthetized with isoflurane and implanted with jugular 
catheters as described previously (Donny et al., 1999). After surgery, rats recovered for a 
minimum of 5 days in the home cages. For the first three days after surgery, the cannulae were 
flushed once daily with 0.1 mL of sterile saline containing heparin (30 U/mL), timentin (66.67 
mg/ml) and streptokinase (9333 U/mL) to maintain catheter patency and prevent infection. After 
this initial post-surgery time period, the flushing solution contained only the heparin and 
timentin. Only rats that passed a chloral-hydrate patency test (60 mg) following the last self-
administration session are included in the data presented. 
2.4.2 Habituation 
 
Each rat was placed in their assigned operant chamber for a 20-min period during which 
time a red house light illuminated the chamber and the nosepokes were removed from the wall. 
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2.4.3 Self-Administration 
Table 1 summarizes the dose order by group. The required number of pokes into the 
active (right) nosepoke resulted in one infusion of the assigned nicotine dose along with a 
cocktail of the other constituents discussed above. Each infusion resulted in the 15-s presentation 
of a stimulus light located above the nosepoke (cued paradigm) and a 1-min time out. Left 
(inactive) nosepokes had no scheduled consequences. Sessions lasted 1 hour and were conducted 
7 days/week.  
 
Table 1. Nicotine doses experienced in each phase for each group 
Group Final n Phase1 
µg/kg/infusion 
Phase 2 
µg/kg/infusion 
Phase 3 
µg/kg/infusion 
Low-High-Low 15 (LHL 15) 14 15 60 15 
Low-High-Low 7.5 (LHL 7.5) 10 7.5 60 7.5 
Low-High-Low 3.75(LHL 3.75) 8 3.75 60 3.75 
Low-High-Low 0.0 (LHL 0.0) 10 0.0 60 0.0 
High-Low 15 (HL 15) 14 60 60 15 
High-Low 7.5 (HL 7.5) 14 60 60 7.5 
High-Low 3.75 (HL 3.75) 14 60 60 3.75 
High-Low 0.0 (HL 0.0) 14 60 60 0.0 
2.4.3.1 Phase 1 
 
At the beginning of the self-administration phase, rats were randomly assigned to one of 
5 acquisition doses of nicotine: 60 µg/kg/infusion (57 rats), 15 µg/kg/infusion (14 rats), 7.5 
µg/kg/infusion (12 rats), 3.75 µg/kg/infusion (10 rats), or 0.0 µg/kg/infusion (vehicle; 12 rats). 
As noted above, due to a technical error, all rats first experienced 8 sessions of exposure to one-
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tenth the assigned nicotine dose (FR 1, 1 session; FR 2, 7 sessions). Upon discovery of the 
technical error, all rats were returned to FR1 at their intended dose. On the first day of the 
experiment one nose-poke was required to receive one infusion (an FR1 schedule of 
reinforcement). Rats experienced 1 session on an FR1 schedule of reinforcement and 7 sessions 
on an FR2 schedule of reinforcement before the ratio was escalated to an FR5 for 25 sessions.   
2.4.3.2 Phase 2 
 
After 25 sessions of self-administration on an FR5 schedule of reinforcement, all rats 
receiving one of the four lower nicotine doses (15, 7.5, 3.75, 0.0 µg/kg/infusion), began 
receiving 60 µg/kg/infusion nicotine with each infusion. Rats that had already been receiving 60 
µg/kg/infusion continued to receive that dose during this phase, meaning that these rats received 
25 more FR5 sessions at the 60 µg/kg/infusion dose. All rats remained at this dose for 15 
sessions.  
2.4.3.3 Phase 3 
Following Phase 2, the 57 rat exposed to the 60 µg/kg/infusion dose during the 
acquisition portion of the experiment (Phase 1) were assigned to one of four groups matched for 
number of infusions over the past three sessions. Rats were assigned to have their nicotine dose 
reduced to either 15 (15 rats), 7.5 (14 rats), 3.75 (14 rats), or 0.0 (vehicle; 14 rats) 
µg/kg/infusion. Rats exposed to one of the four lower doses in the acquisition portion of the 
experiment had their nicotine dose reduced to the same dose used in Phase 1. All rats remained at 
these doses for 16 sessions. Groups that first experienced one of the four lower nicotine doses in 
Phase 1 are referred to as Low-High-Low (LHL) groups along with their reduction dose (e.g 
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LHL7.5 for Low-High-Low group that experienced 7.5 µg/kg/infusion in Phases 1 and 3). 
Groups that experienced 60 µg/kg/infusion during Phase 1 are referred to as High-Low using the 
same shorthand. 
2.5 DATA ANALYSIS 
Data analyses focused on assessing 1) the number of rats meeting a criterion for self-
administration in each Phase of the experiment, 2) whether earned infusions at the end of Phase 3 
were different from Phase 1 for LHL groups, 3) whether the change in earned infusions were 
different for any nicotine dose than for vehicle, and 4) whether earned infusions in Phase 3 were 
different for HL and LHL groups. To assess the proportion of rats self-administering nicotine in 
each phase (the first objective), a criterion was set at an average of at least 25 active responses 
and twice as many mean active as inactive responses over the last three sessions of each Phase. 
All rats that failed to meet the criterion at the end of Phase 2 were excluded from this analysis 
from Phase 3 because they did not experience the manipulation of interest (high nicotine dose 
self-administration).  Proportion of rats meeting the criterion in Phase 1 is reported both with and 
without those failing to meet the criterion in Phase 2. Rats meeting the criterion in Phase 2 are 
included in all analyses (regardless of whether they met or did not meet the criterion in other 
phases. Rats failing to meet the criterion in Phase 2 are excluded from all of the remaining 
analyses. 
To accomplish the second objective, a 4X2 mixed ANOVA compared earned infusions in the 
LHL groups between doses (between-subjects factor, 4 levels) before and after Phase 2 (within-
subjects factor, 2 levels). It was expected that infusions earned before and after Phase 2 may 
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differ for vehicle self-administration, so the third objective was to assess how any differences in 
self-administration for the nicotine groups compared to this difference in vehicle self-
administration. Three 2X2 ANOVAs were conducted comparing each nicotine group to saline 
(between-subjects factor, 2 levels) before and after Phase 2 (within-subjects factor, 2 levels). A 
significant interaction suggests that the effect of high nicotine self-administration on responding 
for low nicotine doses was greater than the effect on responding for vehicle.  
To determine whether the HL and LHL groups were equivalent at the end of Phase 2 (prior to 
reduction but after assignment of the HL groups) four independent-samples t-tests compared 
earned infusions over the last three sessions of Phase 2 for each dose. To determine how the dose 
used for acquisition and the number of sessions at the high nicotine dose affect responding 
following reduction, a 4X2 between-subjects ANOVAs compared the average number of earned 
infusions over the last three sessions of Phase 3 for each nicotine dose (4 levels) and each history 
type (2 levels: LHL, HL).  
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3.0  RESULTS 
Before the dosing error was corrected (when rats were exposed to doses 10 times less 
than their intended acquisition dose), very few rats met the criteria for self-administration. The 
average earned infusions over the last three days before the dosing error was corrected (at an 
FR2) for the LHL15, LHL7.5, LHL3.75, LHL0.0, and HL groups were 5.19 (SE=0.74), 5.50 
(SE=0.84), 5.23 (SE=0.95), 4.92 (SE=0.71), and 5.87 (SE=0.46), respectively. Once rats were 
switched to the correct acquisition doses, rats in the LHL15 and the HL groups readily acquired 
self-administration (Figure 1 shows the earned infusions over Phase 1). Rats in the LHL7.5 
group began to acquire self-administration after approximately 15 sessions on an FR5 schedule. 
At the end of Phase 1, 79%, 58%, 30%, and 16% of rats met the criterion for self-administration 
in the LHL15, LHL7.5, LHL3.75, and LHL0.0 groups, respectively. Of the rats in the HL 
groups, 95% met the criterion for self-administration (60 µg/kg/infusion in Phase 1).  
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Figure 1. Earned infusions across acquisition for all groups 
 
Figure 1. Data points are averages for the number of sessions indicated on the x axis. Error bars represent 
standard errors. 
 
In Phase 2, 13% of rats in the LHL groups failed to meet the criterion for self-
administration. The rats may not have been earning enough infusions in Phase 1 to experience 
the dose change in Phase 2. Of the 6 LHL rats failing to meet the criterion, 3 did not experience 
any infusions during Phase 2, and the other 3 experienced 25, 21, and 1 infusion over the 10 
sessions. Because these rats did not experience the manipulation of interest (self-administration 
of a higher nicotine dose) they were excluded from the remaining analyses. Seven rats were 
excluded from the LHL and HL groups combined (LHL7.5, 2 rats; LHL3.75, 2 rats; LHL0.0, 2 
rats; HL15, 1 rat). Following this exclusion, earned infusions of 60 µg/kg/infusion between LHL 
and HL groups were not significantly different at the end of Phase 2 (ps >0.339).  
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Figure 2 shows the average earned infusions at each of the four doses at the end of Phase 
1 (LHL groups) and Phase 3 (All groups). Earned infusions at the end of Phase 2 are also shown 
for both LHL and HL groups. LHL rats earned significantly more infusions in Phase 3 following 
self-administration of 60 µg/kg/infusion nicotine than in Phase 1, F1,38=17.052, p<0.01. There 
was also a significant main effect of dose, F3, 38=10.920, p<0.01 and a dose by phase interaction, 
F3,38=3.082, p<0.05. The impact of Phase 2 experience was greater on responding for the 7.5 
µg/kg/infusion than on responding for vehicle, F1,18=10.109, p<0.01. Interactions were not 
significant at any other nicotine doses, p>0.05. Earned infusions in Phase 3 were not 
significantly different between LHL and HL groups, F1,90=0.037, p>0.05.  
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Figure 2. Earned infusions at each nicotine dose in Phase 1 (LHL groups), Phase 2, and Phase 3 
(LHL & HL groups) 
 
Figure 2. Earned infusions over the last three sessions of Phase 1(acquisition phase) (LHL 
groups, filled circles) and Phase 3 (reduction following exposure to 60 µg/kg/infusion nicotine) 
(LHL groups, filled squares; HL groups, open squares). Earned infusions at 60 µg/kg/infusion 
dose are from the last three sessions of Phase 2 for both LHL and HL groups and contain all rats 
for each history type. Bars represent standard errors. Significant effect of phase on LHL groups 
is represented by *. Significant nicotine X phase interaction is represented by #. 
 
Figure 3 shows the average earned infusions for each of the LHL groups and individual 
rats at the end of each phase (average of last three sessions). The distribution at the 15 and 7.5 
µg/kg/infusion doses was highly variable in both Phases 1 and 3, with some rats failing to meet 
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the criterion for self-administration and other rats having high rates of self-administration. The 
percentage of rats meeting the criterion for self-administration at the end of Phase 3 was 93%, 
100%, 63%, and 80% for the LHL15, LHL7.5, LHL3.75, and LHL0.0 groups, respectively. The 
percentage of rats meeting the criterion for the HL groups was 100%, 100%, 79%, and 50% for 
the HL15, HL7.5, HL3.75, and HL0.0 groups, respectively. For comparison to Phase 1, after 
excluding the rats that failed to meet the criterion in Phase 2, the percentage of rats meeting the 
criterion in Phase 1 for the LHL15, LHL7.5, LHL3.75, and LHL0.0 groups was 79%, 70%, 38%, 
and 20%.There was little variability in any of the LHL groups during Phase 2 when rats were 
exposed to 60 µg/kg/infusion. The average earned infusions in the LHL3.75 µg/kg/infusion 
group during Phase 3 was increased as a result of one rat that had a very high rate of self-
administration.  
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Figure 3. Earned infusions for individual rats in LHL groups in each phase of the experiment. 
 
Figure 3. Earned infusions for each LHL group. The three bars for each group represent earned 
infusions during a different phase for the same group of rats. All groups experienced the 
indicated dose in Phases 1 and 3. During Phase 2 all rats were switched to 60 µg/kg/infusion of 
nicotine. Bars represent group averages, and points represent data from individual rats.  
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4.0  DISCUSSION 
The present study found that more than half of the rats given the opportunity to acquire 
nicotine self-administration did so when the nicotine dose was 7.5 µg/kg/infusion or greater. Rats 
self-administered low doses of nicotine at a higher rate after experience self-administering a high 
nicotine dose. Rats also self-administered a vehicle of other cigarette constituents paired with a 
nicotine associated stimulus at a higher rate after having a history of high nicotine dose self-
administration. A history of high dose nicotine self-administration had the greatest impact at a 
middle dose (7.5 µg/kg/infusion). Additionally, the rate of self-administering low doses of 
nicotine (and vehicle) was not affected by whether rats acquired self-administration at a low dose 
before having their dose changed to the high nicotine dose.  
In the current study, an increase in self-administration of vehicle was observed following 
the Phase 2 experience of self-administering a higher nicotine dose, indicating that, for an 
unknown period of time, even if nicotine were removed from cigarettes completely, current 
smokers could continue to smoke at a higher rate than individuals who would be starting to 
smoke. Following nicotine reduction, 50-80% of rats self-administering vehicle continued to 
meet our criterion for self-administration. The increase in responding for vehicle is indicative of 
an overall upward shift in the dose-response curve. The peak of the curve as well as the lowest 
level of responding may be increased following experience with a high dose of nicotine.  
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Increased responding for vehicle following self-administration of 60 µg/kg/infusion could 
be related to several mechanisms. Even after nicotine was removed, the operant chamber and 
active nosepoke will continue to function as discriminative stimuli, signaling the availability of 
nicotine, until extinction is complete (Skinner, 1953). Also, the presentation of the light cue 
(which was paired with nicotine in Phase 2) likely maintains responding as a conditioned reinforcer. 
After many presentations of the light without nicotine, rats will learn that the light and nicotine 
are no longer associated. For smokers, the contexts in which they engage in smoking behavior 
and conditioned reinforcers (e.g., taste of a cigarette) will continue to maintain behavior after 
nicotine reduction for some time. In the present study, behavior was maintained over 16 1-hour 
sessions. Another study showed that responding was maintained after nicotine removal over 60 
sessions until cues were finally removed (Cohen, Perrault, Griebel, & Soubrie, 2005).  These 
data suggest that the process of extinction could be very prolonged. Furthermore, rat self-
administration models may overestimate the speed of extinction because learning and extinction 
occur in one context, the operant chamber. For human smokers, nicotine has been paired with 
cues in many contexts, and extinction would likely need to take place in many or all of those 
contexts, increasing the time until behavior is fully extinguished (Wing & Shoaib, 2008). The 
present study illustrates the need for research investigating methods that may facilitate 
extinction. For example, a novel cue could be presented during extinction (e.g., a cigarette 
flavoring), signaling that nicotine is no longer available (Donny et al., 2012). 
Another possibility is that a history of exposure to nicotine may increase the reinforcing 
value of the cocktail constituents. Thus far, there is nothing in the literature to suggest that 
nicotine may shift the reinforcing value of the constituents used here. However, research on these 
constituents is sparse, and experiments have not been designed to test this possibility. The five 
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minor alkaloids employed here (cotinine, myosmine, anatabine, anabasine, and nornicotine) have 
a similar chemical structure to nicotine (Huang & Hsieh, 2007), and it is possible that a history 
of nicotine exposure could increase sensitivity to these constituents.  
In the present study, rats self-administered nicotine at a higher rate following experience 
self-administering a high dose of nicotine. Much of this increase may be due to the upward shift 
in the dose-response curve caused by at least one of the mechanisms discussed above. However, 
a larger effect of high nicotine dose self-administration took place at a middle dose (7.5 
µg/kg/infusion). During acquisition, this dose appeared to be on the ascending limb of the dose-
response curve. The larger increase in self-administration at this dose may be indicative of a 
leftward shift in the dose-response curve. If the ascending limb of the dose-response curve is 
sharp, then a leftward shift in the dose-response curve would be expected to produce the greatest 
increase in self-administration on the ascending limb. A leftward shift in the dose-response curve 
would indicate that experience self-administering a high nicotine dose caused rats to be more 
sensitive to nicotine than they were prior to that experience.  
Another interpretation of the data presented here is that the 7.5 µg/kg/infusion dose in 
Phase 3 increased the value of the light cue as a reinforcer through reinforcement enhancement 
(Donny et al., 2003; Palmatier et al., 2006).  Nicotine has been shown to increase responding for 
a moderately reinforcing stimulus, regardless of whether or not the nicotine is delivered 
contingent on any response. (Donny et al., 2003), a process called reinforcement enhancement. 
This process is separate from the primary reinforcing effects of nicotine. In Phase 3, the light cue 
became a reinforcer through its pairing with nicotine. It may be that in Phase 1, the light cue did 
not function as a reinforcer for rats not meeting the criterion for self-administration (as was true 
for many rats in the LHL7.5 group). After exposure to a higher nicotine dose, the light cue is 
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now functioning as a reinforcer, and the nicotine dose is sufficient for producing enhancement. 
At lower doses (at or below 3.75 µg/kg/infusion), there may not be enough nicotine received to 
produce enhancement of the light cue. At higher doses, nicotine may have been enhancing the 
value of the light cue in Phase 1, so no additional enhancement was seen in Phase 3.  
 The distributions of earned infusions presented in Figure 3 highlight inter-
individual variability even within a single history of nicotine exposure. Doses above the 
threshold for reinforcement but which have historically been on the ascending limb of the dose-
response curve (7.5 and 15 µg/kg/infusion) seemed to produce the most variability, with some 
rats having very high rates of behavior and some rats not meeting the criterion for self-
administration. At the highest dose tested (60 µg/kg/infusion), rats that met the criterion for 
reinforcement self-administered with very little variability. At the lowest end of the dose range, 
rates of self-administration were generally low. Research investigating the sources of variability 
in response to nicotine reduction may be useful in identifying at-risk groups in humans.  
In the present study, self-administration rates were the same in Phase 3 for LHL and HL 
rats. Rats in the HL groups experienced 33 more total sessions at the 60 µg/kg/infusion dose than 
the LHL rats. Despite the difference in exposure to the higher nicotine dose, rates of self-
administration following reduction were strikingly similar. These data indicate that the effect of 
high nicotine dose self-administration is not increased by the duration of self-administration. 
These data may indicate that the length of time an individual has been smoking will not affect 
their rate of smoking following nicotine reduction. However, in the present study, rats were 
exposed to nicotine using a limited-access model (1-h of possible self-administration per day). 
The duration of high nicotine self-administration may have a greater impact using an extended 
access model.  
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These data are reassuring from a policy perspective. If the nicotine content in cigarettes 
were reduced, it is unlikely that there will be much data examining how a nicotine reduction 
policy will affect individuals who may start smoking for the first time at a reduced level. 
However, the data in the present study suggest that a dose of nicotine that reduced smoking in 
current smokers is likely to have an even greater impact on new smokers. Rates of smoking are 
likely to be even lower for individuals who never smoked cigarettes with a higher nicotine 
content. If clinical data support nicotine reduction as an effective strategy for reducing public 
harm, data like these will be important in determining the potential impact on individuals who 
have not yet started smoking. Future self-administration research should continue to address 
concerns about acquisition. Because most smokers begin smoking in adolescents, research 
addressing nicotine reduction in adolescent animals would be especially beneficial.  
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